Skip to main content

Takara Bio to Distribute Exiqon Products in Asia

NEW YORK (GenomeWeb News) – Takara Bio will distribute Exiqon's miRCURY LNA products in Asia beginning in January 2013, Exiqon announced today.

Takara will market the microRNA research tools in Japan, China, Hong Kong, South Korea, and India. It also will launch research services in the region using Exiqon's products in December 2012.

"Asia is an important growth market where we expect customers will benefit from our combined efforts with Takara Bio to meet customer demand for high-quality research products," Henrik Pfundheller, SVP of sales and marketing for Exiqon, said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.